Fresenius Medical Care
A healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Launch date
Employees
Market cap
CAD16.3b
Enterprise valuation
CAD32.3b (Public information from Sep 2024)
Share price
€37.36 FME.F
Bad Homburg Hesse (HQ)
Notable known LPs: Fresenius AG
Financials
Estimates*
EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 17.9b | 17.6b | 19.4b | 19.5b | 19.4b | 20.1b | 20.9b |
% growth | 2 % | (1 %) | 10 % | - | - | 3 % | 4 % |
EBITDA | 2.3b | 1.9b | 1.6b | 3.4b | 3.3b | 3.7b | 3.9b |
% EBITDA margin | 13 % | 11 % | 8 % | 18 % | 17 % | 18 % | 19 % |
Profit | 1.2b | 969m | 673m | 499m | 648m | 934m | 1.1b |
% profit margin | 7 % | 5 % | 3 % | 3 % | 3 % | 5 % | 5 % |
EV / revenue | 1.8x | 1.6x | 1.1x | 1.1x | 1.0x | 1.0x | 0.9x |
EV / EBITDA | 13.5x | 14.8x | 13.2x | 6.4x | 6.0x | 5.3x | 4.7x |
R&D budget | 194m | 221m | 229m | 232m | - | - | - |
R&D % of revenue | 1 % | 1 % | 1 % | 1 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Corporate spinout | |
N/A | N/A | IPO | |
N/A | $39.0m | Post IPO Equity | |
N/A | $4.8m | Post IPO Equity | |
N/A | $6.1m | Post IPO Equity | |
* | N/A | €1.3b | Post IPO Debt |
N/A | €1.5b | Post IPO Debt | |
* | N/A | - | |
* | $318k | Post IPO Equity | |
* | $209k | Post IPO Equity | |
Total Funding | - |
Related Content
Recent News about Fresenius Medical Care
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Fresenius Medical Care
EditACQUISITION by Fresenius Medical Care Aug 2011
exited
ACQUISITION by Fresenius Medical Care Aug 2017
exited
ACQUISITION by Fresenius Medical Care Nov 2016
ACQUISITION by Novo Nordisk Jun 2020
ACQUISITION by Fresenius Medical Care Nov 2007